CA
TNDM icon

Clearstead Advisors’s Tandem Diabetes Care TNDM Stock Holding History

Clearstead Advisors’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$529 Buy
+35
New +$611 ﹤0.01% 2904
2025
Q4 		– Sell
-658
Closed -$7.99K – 3237
2025
Q3 		$7.99K Buy
658
+591
+882% +$8K ﹤0.01% 1992
2025
Q2 		$1.25K Buy
+67
New +$1.33K ﹤0.01% 2407
2024
Q4 		– Sell
-16
Closed -$679 – 2187
2024
Q3 		$679 Buy
+16
New +$678 ﹤0.01% 1941

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Clearstead Advisors's TNDM Position: Q2 2026 in Review

Clearstead Advisors opened a new position in Tandem Diabetes Care (TNDM) in Q2 2026: 35 shares worth $529. The stake represents ﹤0.01% of the portfolio and ranks #2904 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in TNDM as recently as Q3 2025.

Clearstead Advisors first reported a position in TNDM in Q3 2024 and has held it in 4 quarters since. The position peaked at $7.99K in Q3 2025. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Clearstead Advisors held 35 shares of Tandem Diabetes Care worth $529 as of Q2 2026.
  • Tandem Diabetes Care was a new Clearstead Advisors position in Q2 2026.
  • Tandem Diabetes Care made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #2904 holding.
  • Clearstead Advisors first reported a position in Tandem Diabetes Care in Q3 2024 and has held it in 4 quarters since.
  • Clearstead Advisors's Tandem Diabetes Care position peaked at $7.99K in Q3 2025.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.